Sector ratings Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
|
End-of-day quote
Wiener Boerse
2026-08-21
|
5-day change | 1st Jan Change | ||
| 59.60 EUR | -1.57% |
|
+2.14% | -5.85% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1,109B | A | |||||||
| 644B | - | BBB | - | - | ||||
| 463B | AA | - | ||||||
| 371B | AA | |||||||
| 301B | AAA | |||||||
| 256B | A | |||||||
| 234B | A | |||||||
| 205B | A | |||||||
| 178B | AA | |||||||
| 158B | A | |||||||
| 137B | AA | |||||||
| 134B | A | |||||||
| 109B | AA | |||||||
| 105B | AA | |||||||
| 73.59B | AA | |||||||
| 58.59B | AA | |||||||
| 55.78B | AA | |||||||
| 48.45B | AA | |||||||
| 42.89B | - | |||||||
| Average | 246.49B | AA | |||||||
| Weighted average by Cap. | AA |
Select your edition
All financial news and data tailored to specific country editions
